Vial
PrivateLast Round
Debt
May 28, 2025
Total Funding Raised
$134M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vial is a next-generation pharmaceutical company that operates a tech-enabled clinical research organization (CRO) and develops computationally designed therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vial Comparables
Compare Vial with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindus Health | 89% | |
| Curebase | 84% | |
| Paradigm Health | 81% | |
Vial Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 28, 2025 | ||||
| Series B | Nov 30, 2022 | ||||
| Series A | Nov 1, 2022 | ||||
| Seed | Apr 1, 2021 |
Key People
Founding team and executive leadership
Vial Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Byers Capital | Series A, Series B |
| Buckley Ventures | Series A, Seed |
| General Catalyst | Series A, Series B |
| BoxGroup | Series A, Series B |
| Base10 Partners | Series A |
| ATEL Ventures | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Developing an IL-13 x TSLP bispecific antibody for respiratory indications.
- Apr 1, 2026
Grown rapidly to a team of 100+ employees since October 2020.
Vial Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vial's valuation, stock price, and market status.